Commissioning of a 142.4 MeV ultra‐high dose rate (UHDR) proton beamline in a synchrotron‐based proton therapy system
Medical Physics · 2025
DOI: 10.1002/mp.18008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Physics, 2025. Verfasst von Lingshu Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Proton Therapy, Synchrotrons, Radiation Dosage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Recent studies suggest that radiotherapy at ultrahigh dose rates (>40 Gy/s, FLASH) offers normal tissue sparing effects while maintaining tumor control. There is significant interest in preclinical studies investigating the mechanism of FLASH sparing effects.
Purpose
This study aims to commission a fixed proton beamline within a synchrotron‐based proton therapy system for preclinical proton FLASH research.
Methods
Modifications were made to the Hitachi PROBEAT‐CR synchrotron system to enhance RF extraction power and increase proton beam current at 142.4 MeV. A high‐speed electrometer and an optimized transmission ion chamber (IC) were implemented for ultra‐high dose rate (UHDR) beam monitoring and delivery, replacing the conventional beam monitoring IC. Beam output was measured using a Faraday cup in both UHDR and clinical modes. Gafchromic film measurements and Monte Carlo simulations were employed to validate dose delivery in a solid water phantom with various spot scanning patterns.
Results
The calibration of transmission IC against Faraday cup shows sufficient charge collection efficiency at both clinical dose rates and UHDR. The UHDR PBS beamline demonstrates better than 1% reproducibility and linearity in the absolute beam output. Due to the limited charge per spill, the delivered dose per spill is inversely proportional to the field size. However, the system can deliver up to 41.4 Gy (268.1 Gy/sec) at 2 cm depth with a field size (FWHM) of 8.2 mm, demonstrating suitability for small animal proton FLASH irradiation studies.
Conclusion
We successfully commissioned a fixed beam proton UHDR PBS beamline in a synchrotron‐based proton therapy system. Despite synchrotron‐specific system constraints, our system enables controlled UHDR delivery for preclinical proton FLASH research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Center for Technology Innovation-Energy, Research and Development Group, Hitachi, Ltd., Hitachi-shi, Ibaraki-ken, Japan.
- Pyramid Technical Consultants, Inc., Boston, Massachusetts, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Yin, L., Sforza, D., Miles, D., Masumi, U., Ota, K., Jia, X., & Li, H. (2025). Commissioning of a 142.4 MeV ultra‐high dose rate (UHDR) proton beamline in a synchrotron‐based proton therapy system. Medical Physics. https://doi.org/10.1002/mp.18008
Vancouver
Yin L, Sforza D, Miles D, Masumi U, Ota K, Jia X, et al. Commissioning of a 142.4 MeV ultra‐high dose rate (UHDR) proton beamline in a synchrotron‐based proton therapy system. Medical Physics. 2025. doi:10.1002/mp.18008
BibTeX
@article{Yin2025,
author = {Yin, Lingshu and Sforza, Daniel and Miles, Devin and Masumi, Umezawa and Ota, Kan and Jia, Xun and Li, Heng},
title = {Commissioning of a 142.4 MeV ultra‐high dose rate (UHDR) proton beamline in a synchrotron‐based proton therapy system},
journal = {Medical Physics},
year = {2025},
doi = {10.1002/mp.18008}
}
EUVIMED